Implementation of teleHealth using SKEDit for protein diet education for diabetes patients

Khoirul Rista Abidin; Eka Riana

doi:10.26714/mki.4.4.2021.277-284

Implementation of teleHealth using SKEDit for protein diet education for diabetes patients

Khoirul Rista Abidin^(1*), Eka Riana⁽²⁾

(1) Prodi Teknologi Laboratorium Medis, Politeknik Aisyiyah Pontianak
(2) Prodi Kebidanan, Politeknik Aisyiyah Pontianak
(*) Corresponding Author

Abstract

A protein diet is an alternative to control hyperglycemia and hyperlipidemia conditions in diabetic patients. However, for the program to run optimally, the implementation of technology in the form of TeleHealth is needed to help educate patients on a regular and flexible basis. The purpose of this study was to analyze the effectiveness of implementing TeleHealth using the SKEDIt application for protein diet education in diabetic patients. Methods: This research is a quasi-experimental study, pre and post-test with a control group. The subjects involved were 20 diabetic patients, divided into 2 groups (intervention and control). Parameters analyzed were lipid profile and blood glucose levels. There was no difference in lipid profile and blood glucose levels between the intervention and control groups (p > 0.05). However, there was a difference between the pre and post-test on cholesterol parameters in the lipid profile examination of the control group: p=0.031 and LDL p=0.021 (p <0.05). Implementation of TeleHealth using SKEDit may be an effective recommendation to support health education methods but needs to be supported by good patient compliance.

Keywords

Diabetes; TeleHealth; SKEdit; Hyperlipidemia; Protein

Full Text:

PDF

References

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157. https://doi.org/10.1016/j.diabres.2019.107843.

International Diabetes Federation I. IDF Diabetes Atlas Update. 2015.

Sheleme T, Mamo G, Melaku T, Sahilu T. Prevalence, patterns and predictors of chronic complications of diabetes mellitus at a large referral hospital in Ethiopia: A prospective observational study. Diabetes, Metab Syndr Obes Targets Ther 2020;13:4909–18. https://doi.org/10.2147/DMSO.S281992.

Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova M V, et al. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol 2018;17:150. https://doi.org/10.1186/s12933-018-0787-8.

Aastha Chawla, Rajeev Chawla SJ. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab 2016;20. https://doi.org/10.4103/2230-8210.183480.

Barot M, Gokulgandhi MR, Patel S, Mitra AK. Microvascular complications and diabetic retinopathy: recent advances and future implications. Future Med Chem 2013;5:301–14. https://doi.org/10.4155/fmc.12.206.

Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32 Suppl 1:S62–7. https://doi.org/10.2337/dc09-S062.

Chakrabarti P, Kim JY, Singh M, Shin Y-K, Kim J, Kumbrink J, et al. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway. Mol Cell Biol 2013;33:3659–66. https://doi.org/10.1128/MCB.01584-12.

Guilherme A, Virbasius J V, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:367–77. https://doi.org/10.1038/nrm2391.

Marshall JA, Bessesen DH. Dietary Fat and the Development of Type 2 Diabetes. Diabetes Care 2002;25:620 LP – 622. https://doi.org/10.2337/diacare.25.3.620.

Rhee E-J, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, et al. 2018 Guidelines for the management of dyslipidemia. Korean J Intern Med 2019;34:723–71. https://doi.org/10.3904/kjim.2019.188.

Ke Q, Chen C, He F, Ye Y, Bai X, Cai L, et al. Association between dietary protein intake and type 2 diabetes varies by dietary pattern. Diabetol Metab Syndr 2018;10:48. https://doi.org/10.1186/s13098-018-0350-5.

Lacroix M, Gaudichon C, Martin A, Morens C, Mathé V, Tomé D, et al. A long-term high-protein diet markedly reduces adipose tissue without major side effects in Wistar male rats. Am J Physiol Regul Integr Comp Physiol 2004;287:R934-42. https://doi.org/10.1152/ajpregu.00100.2004.

Lee K, Jin H, Chei S, Lee J-Y, Oh H-J, Lee B-Y. Dietary Silk Peptide Prevents High-Fat Diet-Induced Obesity and Promotes Adipose Browning by Activating AMP-Activated Protein Kinase in Mice. Nutrients 2020;12:201. https://doi.org/10.3390/nu12010201.

Zhao W-T, Luo Y, Zhang Y, Zhou Y, Zhao T-T. High protein diet is of benefit for patients with type 2 diabetes: An updated meta-analysis. Medicine (Baltimore) 2018;97:e13149. https://doi.org/10.1097/MD.0000000000013149.

Hamdy O, Horton ES. Protein content in diabetes nutrition plan. Curr Diab Rep 2011;11:111–9. https://doi.org/10.1007/s11892-010-0171-x.

Posthauer ME, Banks M, Dorner B, Schols JMGA. The role of nutrition for pressure ulcer management: national pressure ulcer advisory panel, European pressure ulcer advisory panel, and pan pacific pressure injury alliance white paper. Adv Skin Wound Care 2015;28:175–90. https://doi.org/10.1097/01.ASW.0000461911.31139.62.

Wang X, Son M, Meram C, Wu J. Mechanism and Potential of Egg Consumption and Egg Bioactive Components on Type-2 Diabetes. Nutrients 2019;11:357. https://doi.org/10.3390/nu11020357.

Klonoff DC. Using telemedicine to improve outcomes in diabetes--an emerging technology. J Diabetes Sci Technol 2009;3:624–8. https://doi.org/10.1177/193229680900300401.

Andodo C, Haryanti F, Widyandana W. Telenursing Using SKEDit To Educate Parents with Thalassemia Children. J Keperawatan Soedirman; Vol 14, No 3 2019.

Adebawo O, Salau B, Ezima E, Oyefuga O, Ajani E, Idowu G, et al. Fruits and vegetables moderate lipid cardiovascular risk factor in hypertensive patients. Lipids Health Dis 2006;5:14. https://doi.org/10.1186/1476-511X-5-14.

Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag 2005;1:189–99.

Jeganathan S, Prasannan L, Blitz MJ, Vohra N, Rochelson B, Meirowitz N. Adherence and acceptability of telehealth appointments for high-risk obstetrical patients during the coronavirus disease 2019 pandemic. Am J Obstet Gynecol MFM 2020;2:100233. https://doi.org/10.1016/j.ajogmf.2020.100233.

Gannon MC, Nuttall FQ. Effect of a High-Protein, Low-Carbohydrate Diet on Blood Glucose Control in People With Type 2 Diabetes. Diabetes 2004;53:2375 LP – 2382. https://doi.org/10.2337/diabetes.53.9.2375.

Conway CM, Kelechi TJ. Digital Health for Medication Adherence in Adult Diabetes or Hypertension: An Integrative Review. JMIR Diabetes 2017;2:e20–e20. https://doi.org/10.2196/diabetes.8030.

Ciemins E, Coon P, Peck R, Holloway B, Min S-J. Using telehealth to provide diabetes care to patients in rural Montana: findings from the promoting realistic individual self-management program. Telemed J E Health 2011;17:596–602. https://doi.org/10.1089/tmj.2011.0028.

Sattar N, Rawshani A, Franzén S, Rawshani A, Svensson A-M, Rosengren A, et al. Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks. Circulation 2019;139:2228–37. https://doi.org/10.1161/CIRCULATIONAHA.118.037885.

Zou W, Ni L, Lu Q, Zou C, Zhao M, Xu X, et al. Diabetes Onset at 31–45 Years of Age is Associated with an Increased Risk of Diabetic Retinopathy in Type 2 Diabetes. Sci Rep 2016;6:38113. https://doi.org/10.1038/srep38113.